Ablative 2940-nm Er: YAG Fractional Laser for the Treatment of Male Androgenetic Alopecia with Predominantly Frontal Hairline Recession

The study investigates the use of the ablative 2940-nm Er: YAG fractional laser for treating male androgenetic alopecia (AGA) with a focus on patients experiencing predominantly frontal hairline recession. Traditional treatments like topical minoxidil and oral finasteride have shown limited effectiveness, especially in moderate-to-severe cases. The research aims to explore alternative methods to address the specific challenge of receding frontal hairlines in AGA patients. The findings suggest that the 2940-nm Er: YAG fractional laser could be a promising option, potentially offering better outcomes for this subgroup of AGA patients.